• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC; MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC; MOZ Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hernia (2240)
Event Type  Injury  
Event Description
Tore her hernia [hernia perforation].Case narrative: initial information was received on 12-sep-2023 regarding a solicited valid serious case from a patient in the scope of patient support program "psp_saus.Tjo.012".Patient id: (b)(6); country: united states.Study title: sanofi patient connection.This case involves a 54 years old female patient who tore her hernia while being treated with medical device hylan g-f 20, sodium hyaluronate [synvisc one] (in right knee) the patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.On an unknown date, the patient started using synvisc one (hylan g-f 20, sodium hyaluronate) 48 mg/6ml injection in 10 ml syringe at dose of 6 ml in right knee (lot, expiry date, frequency, route, indication - unknown).Information on batch number was requested.On an unknown date, after unknown latency, the patient tore her hernia (hernia perforation) and she need a walker.This event was leading to disability and was assessed as medically significant.When asked about the prescription information, the patient services representative noted that was what was indicated on the enrollment form.At the time of the report, it was unknown if synvisc-one is continued or not.No additional information at the time of the report.Action taken: not applicable.It was not reported if the patient received a corrective treatment for the event (tore her hernia).At time of reporting, the outcome was unknown for the event tore her hernia.Reporter causality: not reported.Company causality: not reportable.
 
Event Description
Tore her hernia [hernia perforation].Case narrative: initial information was received on 12-sep-2023 regarding a solicited valid serious case from a patient in the scope of patient support program "psp_saus.Tjo.012".Patient id: (b)(6); country: united states.Study title: sanofi patient connection.This case is linked to case (b)(4) (multiple devices suspect for same patient).This case involves a 54 years old female patient who tore her hernia while being treated with medical device hylan g-f 20, sodium hyaluronate [synvisc one] (in right knee).The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.On an unknown date, the patient started using synvisc one (hylan g-f 20, sodium hyaluronate) 48 mg/6ml injection in 10 ml syringe at dose of 6 ml in right knee (lot, expiry date, frequency, route, indication - unknown).Information on batch number was requested.On an unknown date, after unknown latency, the patient tore her hernia (hernia perforation) and she need a walker.This event was leading to disability and was assessed as medically significant.When asked about the prescription information, the patient services representative noted that was what was indicated on the enrollment form.At the time of the report, it was unknown if synvisc-one is continued or not.No additional information at the time of the report.Action taken: not applicable.Corrective treatment: she need a walker.At time of reporting, the outcome was unknown for the event tore her hernia.Reporter causality: not reported.Company causality: not reportable.Additional information was received on 12-sep-2023 from patient: corrective treatment was added.Text was amended accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
MOZ
Manufacturer (Section D)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key17774555
MDR Text Key323744195
Report Number2246315-2023-00098
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Other;
Patient SexFemale
-
-